The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.50
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.857%)
Open: 17.75
High: 17.75
Low: 17.75
Prev. Close: 17.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix partner gets approval to make SlimBiome in India

Thu, 11th Apr 2019 11:16

(Sharecast News) - OptiBiotix Health announced on Thursday that it has received a licence from the Food Standards and Safety Authority India (FSSAI) for its weight management product 'SlimBiome' to be manufactured in the country.The AIM-traded firm said the approval was gained by its manufacturing partner Zeon Life Sciences for both SlimBiome itself, and SlimBiome-containing products.It said FSSAI licence approval involved both ingredient and quality verification to ensure the product and manufacturing process was of a high standard, and was an essential regulatory requirement to manufacture and distribute food products in India.The licence approval would allow Zeon to fulfil orders arising from OptiBiotix's recent visit to India for SlimBiome and SlimBiome-containing products in its own manufacturing site. Its board described it as a "strategic step" to add manufacturing in Asia to the supply chain, and extend the market opportunity for its patented weight management product into the Indian market with an established partner.Zeon boasted a number of large Indian and international healthcare companies such as Danone, GNC, Decathlon, Sun Pharma and Herbalife among its customers, and was awarded 'Nutraceutical Manufacturing Company of the Year' in 2017 by the Associated Chambers of Commerce and Industry of India."We are really pleased that Zeon has received FSSAI approval to manufacture SlimBiome in India," said OptiBiotix chief executive officer Stephen O'Hara."This allows them to fulfil partner orders and meet the needs of other partners interested in selling SlimBiome and SlimBiome-containing products in India."We have been really impressed with the professionalism of Zeon and the speed at which they are creating interest and orders for our products in India."O'Hara said achieving FSSAI approval rapidly was a significant achievement, describing it as an important step in completing the supply chain to meet the needs of existing and new corporate partners in India and southern Asia."This agreement is another step in a strategy designed to build multiple revenue streams from ingredient sales, and white label and own label branded consumer and pharmaceutical products across multiple channels with industry partners from around the world."
More News
26 Sep 2022 14:18

OptiBiotix launching new product in deal with Shandong Longlive

(Sharecast News) - Life science company OptiBiotix Health has signed an exclusive distribution agreement with Shandong Longlive Biotechnology, it announced on Monday, for the distribution of Longlive's unique xylooligosaccharide (XOS) prebiotic into the human nutrition markets in Europe and Africa.

Read more
20 Sep 2022 20:50

TRADING UPDATES: Gaming Realms, Northcoders revenue up; Boku wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Sep 2022 11:37

OptiBiotix launches range into large Indian chemist chain

(Sharecast News) - OptiBiotix Health announced on Tuesday that its subsidiary OptiBiotix Ltd launched its 'GoFigure' range with Apollo Hospitals & Pharmacies on 18 September.

Read more
14 Sep 2022 14:25

IN BRIEF: OptiBiotix Health subsidiary signs Asia Pacific agreement

OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Says its wholly owned subsidiary OptiBiotix Ltd has signed a services agreement with Nutraconnect Pte Ltd for the Asia Pacific region. Notes that Nutraconnect will develop and implement the go-to-market strategy for prebiotics ingredients SlimBiome and LeanBiome. "Nutraconnect is a nutraceutical business growth acceleration service headquartered in Singapore," the company says.

Read more
24 Aug 2022 15:38

OptiBiotix tumbles as it warns of 'materially lower' sales

(Sharecast News) - Life sciences company OptiBiotix Health said in a trading update on Wednesday that, based on initial figures, it expected first-half sales in its new structure to be "materially lower than expected" at around £0.12m.

Read more
24 Aug 2022 10:43

OptiBiotix shares plunge on "very difficult trading" in half-year

(Alliance News) - OptiBiotix Health PLC on Wednesday lamented a strenuous half-year but eyed growing sales and business, seeing itself in a strong position.

Read more
24 Aug 2022 10:32

AIM WINNERS & LOSERS: Gfinity up on Athlos launch; OptiBiotix slides

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
19 Jul 2022 15:57

UK shareholder meetings calendar - next 7 days

Wednesday 20 July 
ADM Energy PLC AGM
Alkemy Capital Investments PLCAGM
DeepVerge PLCAGM
easyJet PLCGM re purchase of 56 Airbus A320neo family aircraft & conversion of 18 A320neo family aircraft
Fidelity China Special Situations PLCAGM
HarbourVest Global Private Equity LtdAGM
HICL Infrastructure PLCAGM
Novacyt SAAGM 
Plaza Centers NVAGM
Premier Foods PLCAGM
Royal Mail PLCAGM
Triad Group PLCAGM
Wynnstay Properties PLCAGM & GM re share buyback
Thursday 21 July  
Big Yellow Group PLCAGM
Evgen Pharma PLCAGM
Experian PLCAGM
Halma PLCAGM
Intermediate Capital Group PLCAGM
Johnson Matthey PLCAGM
Octopus AIM VCT PLCAGM
Pennon Group PLCAGM
Pires Investments PLCGM re offer from Tern PLC
QinetiQ Group PLCAGM
SSE PLCAGM
Tern PLCGM re offer for Pires Investments PLC
Vp PLCAGM
Workspace Group PLCAGM
Zephyr Energy PLCAGM
Friday 22 July  
Chesterfield Resources PLCAGM
Homeserve PLCGM re offer by affiliates of Brookfield Infrastructure Partners LP
JD Sports Fashion PLCAGM
Landore Resources LtdAGM
President Energy PLCAGM
United Utilities Group PLCAGM
WANdisco PLCAGM
Monday 25 July 
BP Marsh & Partners PLCAGM
Keras Resources PLCAGM
Keras Resources PLCGM re share consolidation
Tuesday 26 July 
AO World PLCAGM
Bytes Technology Group PLCAGM
Dekel Agri-Vision PLCAGM
Firering Strategic Minerals PLCAGM
Mitie Group PLCAGM
Momentum Multi-Asset Value Trust PLCAGM
nanosynth group PLCAGM
NewRiver REIT PLCAGM
Ninety One PLC & LtdAGM
OnTheMarket PLCAGM
OptiBiotix Health PLCAGM
Telecom Plus PLCAGM
Vodafone Group PLCAGM
Xeros Technology Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Jun 2022 12:19

IN BRIEF: OptiBiotix Health annual profit up; confident in prospects

OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Reports higher profit and revenue in 2021 as probiotic business sells more. Pretax profit rises to GBP6.2 million from GBP5.7 million in 2020. Revenue from contracts with customers grows 45% to GBP2.2 million from GBP1.5 million.

Read more
20 Jun 2022 11:03

OptiBiotix welcomes Steen Anderson as new CEO of ProBiotix spin-off

(Alliance News) - OptiBiotix Health PLC on Monday noted the change in leadership at its recently AQSE-listed spin-off company ProBiotix Health PLC.

Read more
31 Mar 2022 15:15

IN BRIEF: OptiBiotix spin-off ProBiotix Health starts trading on Aquis

ProBiotix Health PLC - developing probiotics to tackle cardiovascular disease and other lifestyle conditions - Starts trading on Aquis Stock Exchange on Thursday after raising GBP2.5 million in initial public offering. ProBiotix sells 11.9 million shares at 21 pence each, giving the company a GBP25.5 million market capitalisation upon admission. No trades of the stock are reported by AQSE on Thursday. ProBiotix made GBP1.1 million in sales in 2021.

Read more
17 Mar 2022 16:37

OptiBiotix set to list ProBiotix subsidiary on AQSE

(Sharecast News) - OptiBiotix Health announced its intention to list its subsidiary ProBiotix Health on the AQSE Growth Market of the Aquis Stock Exchange on Thursday.

Read more
28 Feb 2022 19:41

TRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
28 Feb 2022 14:24

OptiBiotix Health ends year in line with expectations

(Sharecast News) - OptiBiotix Health updated the market on its trading ahead of its final results on Monday, reporting total invoiced sales of £2.2m in 2021 - an increase of 46.7% year-on-year, and in line with market expectations.

Read more
9 Feb 2022 18:13

TRADING UPDATES: Chaarat Gold beats guidance for 2021 Kapan output

TRADING UPDATES: Chaarat Gold beats guidance for 2021 Kapan output

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.